IMU 9.26% 5.9¢ imugene limited

10c target in 12 month , page-9

  1. 5,700 Posts.
    lightbulb Created with Sketch. 413
    "During the twelve months ended 30 June 2013, the Company completed feasibility testing and formulation
    development for two initial Vitamin D formulations which have been enhanced using Imugene? proprietary Linguet
    drug delivery technology."

    Completed!

    Our research has been supported by discussions held with Australian nutraceutical companies. The vitamins and supplements industry is big business in Australia, worth an estimated $1.5bn each year and the industry is growing at up to 12% annually.

    Supported!

    Next should be an agreement!

    In June 2013, Imugene contracted IDT Australia to manufacture its ibuprofen tablets.

    Contracted!
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.9¢
Change
0.005(9.26%)
Mkt cap ! $433.6M
Open High Low Value Volume
5.5¢ 5.9¢ 5.4¢ $1.489M 25.99M

Buyers (Bids)

No. Vol. Price($)
2 35252 5.9¢
 

Sellers (Offers)

Price($) Vol. No.
6.0¢ 1753430 24
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.